The store will not work correctly when cookies are disabled.
N1-[(E)-5-Dihydroxyphosphonyl-pent-2-enyl]-5-fluorouracil
ID: ALA1650759
PubChem CID: 50993950
Max Phase: Preclinical
Molecular Formula: C9H12FN2O5P
Molecular Weight: 278.18
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]c(=O)n(C/C=C/CCP(=O)(O)O)cc1F
Standard InChI: InChI=1S/C9H12FN2O5P/c10-7-6-12(9(14)11-8(7)13)4-2-1-3-5-18(15,16)17/h1-2,6H,3-5H2,(H,11,13,14)(H2,15,16,17)/b2-1+
Standard InChI Key: KCTKUURHXFRJGJ-OWOJBTEDSA-N
Molfile:
RDKit 2D
18 18 0 0 0 0 0 0 0 0999 V2000
1.4282 -13.1483 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
4.2776 -10.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2776 -11.5043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9900 -11.9129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7019 -11.5049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7022 -10.6790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9900 -10.2622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9900 -9.4371 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4165 -11.9173 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9900 -12.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2754 -13.1504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5610 -12.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8500 -13.1483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1392 -12.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7173 -12.7377 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4282 -13.9692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7126 -13.5552 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5618 -10.2685 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
5 9 2 0
4 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 1 1 0
1 15 1 0
2 3 2 0
1 16 2 0
2 7 1 0
1 17 1 0
3 4 1 0
2 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.18 | Molecular Weight (Monoisotopic): 278.0468 | AlogP: -0.20 | #Rotatable Bonds: 5 |
Polar Surface Area: 112.39 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.81 | CX Basic pKa: ┄ | CX LogP: -0.64 | CX LogD: -3.04 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.51 | Np Likeness Score: -0.20 |
References
1. Topalis D, Pradère U, Roy V, Caillat C, Azzouzi A, Broggi J, Snoeck R, Andrei G, Lin J, Eriksson S, Alexandre JA, El-Amri C, Deville-Bonne D, Meyer P, Balzarini J, Agrofoglio LA.. (2011) Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates., 54 (1): [PMID:21128666] [10.1021/jm1011462] |